Physician profile
Tha A Saw
NPI 1083177182
$3,028.54
in general payments reported to CMS, 2019-2025
8 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what 79% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,636 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078 · Travel and Lodging: $680 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.46 |
| Travel and Lodging | $680.10 |
| Education | $269.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,621.62 | 2024-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $648.39 | 2024-2025 | |
| Axsome Therapeutics, INC. | $294.04 | 2025 | Sunosi |
| Fisher & Paykel Healthcare INC | $199.54 | 2025 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $162.66 | 2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $62.69 | 2025 | |
| Noctrix Health, INC. | $24.40 | 2025 | Nidra |
| Harmony Biosciences LLC | $15.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tha Saw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.